控股公司富鲁达同多所大学合作创建单细胞基因组研究中心

  近日，由生物技术仪器业务私人控股公司富鲁达（Fluidigm）同莫纳什大学、墨尔本大学、纽卡斯尔大学及哈德逊医学研究所组成的团队宣布准备创建新型单细胞基因组研究中心。
  位于墨尔本外部的莫纳什健康翻译区域(MHTP)中的医学基因组设备将会建立第一个卓越的单细胞基因组研究中心。
  哈德逊研究所所长Bryan Williams在一份声明中指出，这项多所大学同富鲁达公司的合作将为众多科学家提供几乎来改善富鲁达公司的技术，并且增加其在基因组医学研究领域的地位。
  这五家合作者将共同资助该中心，并且提供相关的基础设施、设备以及来自澳大利亚研究委员会的拨款资助。
  MHTP是哈德逊医学研究所、莫纳什大学以及当地卫生局推进转化医学领域研究的合资项目；早在2月份SciLifeLab就已经在瑞典发起了一项开发单细胞生物研究中心的计划。（转化医学网360zhyx.com）
  以上为转化医学网原创翻译整理，转载请注明出处和链接！
转化医学网推荐的新闻阅读：

Australian Partners Link up With Fluidigm to Open Single-Cell Genomics Center
A consortium including South San Francisco, California-based Fluidigm and Australia's Monash University, the University of Melbourne, the University of Newcastle, and the Hudson Institute of Medical Research today announced the opening of a new single-cell genomics center.

Monash Health Translation Precinct's (MHTP) Medical Genomics Facility outside Melbourne will house the country's first Single-Cell Genomics Centre of Excellence.

"This collaborative partnership with our partner universities and Fluidigm is providing our scientists with access to breakthrough developments in Fluidigm's technology and increasing the opportunities for them to become world leaders in the field of genomics medicine," Hudson Institute Director Bryan Williams said in a statement.

The five partners provided funding for the center, along with a Linkage Infrastructure, Equipment, and Facilities grant from the Australian Research Council.

The MHTP is a joint project of the Hudson Institute of Medical Research, Monash University, and Monash Health to advance translational medicine.

In February, SciLifeLab launched the Swedish National Center for Single-Cell Biology, featuring instruments from Fluidigm.